Bone loss. Factors that regulate osteoclast differentiation: an update. - Wikidata - awgldk - TriplyDB

Bone loss. Factors that regulate osteoclast differentiation: an update.

Bone loss. Factors that regulate osteoclast differentiation: an update.

http://www.wikidata.org/entity/Q24805142

about

Maintenance Infliximab Treatment Is Associated with Improved Bone Mineral Density in Crohn's Disease Nitric oxide and bone The synovio-entheseal complex in enthesoarthritis.A TNF variant that associates with susceptibility to musculoskeletal disease modulates thyroid hormone receptor binding to control promoter activation Molecular profiling of giant cell tumor of bone and the osteoclastic localization of ligand for receptor activator of nuclear factor kappaB Radiographic joint destruction in postmenopausal rheumatoid arthritis is strongly associated with generalised osteoporosis Osteoprotegerin Polymorphisms in a Mexican Population with Rheumatoid Arthritis and Generalized Osteoporosis: A Preliminary Report Aseptic loosening.Antigens of bacteria associated with periodontitis.Adenosine A2A receptor activation prevents wear particle-induced osteolysis Bone turnover and nutritional status in Crohn's disease: relationship to circulating mononuclear cell function and response to fish oil and antioxidants.Effects of intermedin on proliferation, apoptosis and the expression of OPG/RANKL/M-CSF in the MC3T3-E1 osteoblast cell line.Sustained mitogen-activated protein kinase activation with Aggregatibacter actinomycetemcomitans causes inflammatory bone loss Vitamin e and bone structural changes: an evidence-based review.Novel host response therapeutic approaches to treat periodontal diseases.Actinobacillus actinomycetemcomitans lipopolysaccharide-mediated experimental bone loss model for aggressive periodontitis Ectopic osteogenesis and angiogenesis regulated by porous architecture of hydroxyapatite scaffolds with similar interconnecting structure in vivo.Genetic susceptibility to aseptic loosening following total hip arthroplasty: a systematic review.Rooibos flavonoids, orientin and luteolin, stimulate mineralization in human osteoblasts through the Wnt pathway.Nutritional Strategies in the Management of Adult Patients with Inflammatory Bowel Disease: Dietary Considerations from Active Disease to Disease Remission.Effects of TNF Inhibitors on Parathyroid Hormone and Wnt Signaling Antagonists in Rheumatoid Arthritis.Cross-analysis of gene and miRNA genome-wide expression profiles in human fibroblasts at different stages of transformation.iNOS-derived nitric oxide modulates infection-stimulated bone loss.Inhibitory effects of eugenol on RANKL-induced osteoclast formation via attenuation of NF-κB and MAPK pathways.Intermittent PTH(1-34) signals through protein kinase A to regulate osteoprotegerin production in human periodontal ligament cells in vitro.Palm tocotrienol exerted better antioxidant activities in bone than alpha-tocopherol.A p38 mitogen-activated protein kinase inhibitor arrests active alveolar bone loss in a rat periodontitis model.Laboratory markers predict bone loss in Crohn's disease: relationship to blood mononuclear cell function and nutritional status.Effect of simvastatin on kinetics of osteoprotegrin/receptor activator nuclear kappa B Ligand mRNA expression in periapical lesions.The association of osteoprotegerin gene polymorphisms with periodontitis.Effects of denosumab on bone metabolism and bone mineral density with anti-TNF inhibitors, tocilizumab, or abatacept in osteoporosis with rheumatoid arthritis.Teratogenic Effects of Crude Ethanolic Root Bark and Leaf Extracts ofRauwolfia vomitoria(Apocynaceae) on the Femur of Albino Wistar Rat Fetuses

P2860

Q22242347-6AD0AE0F-FF30-45D7-8C00-311A5FC74B1C Q28343869-D2C01633-59C4-492B-8104-BBF74F98AE97 Q33360030-7F8AFF56-8262-4431-8B0A-AF09C1657CB2 Q34999751-2A2185E6-5480-40B6-8C32-C05338ED9926 Q35084886-A41F35B1-1AFB-46C6-B1E5-CA4E7680E86C Q35552836-9F831874-C336-47AB-825F-0BAB7562C510 Q35612713-5FB08D17-054A-4AE1-AEDC-9068DDBE18B2 Q35629551-B2ACA06F-5432-497A-BC2A-2CF0199F5CFE Q35755292-22C81317-33E8-478E-9281-EC9536EDCD6D Q36067491-1CE732E7-8620-4250-AE0C-795139C7A3F0 Q36165341-CC041350-E219-4137-9C03-4112E72DF059 Q36224872-5AC6CE43-7482-42D5-814A-08951D091A00 Q36235672-B38C6AEA-7100-4A65-AE25-31EAD9529139 Q36355362-4AE2D557-7893-4037-8F53-96CD95BF3C14 Q36703987-391E9547-AB60-46B4-8174-FC2BB54CD5B5 Q37195476-1B6C93B2-DE54-40CA-91A4-BD4691B17D72 Q37298394-505D656C-AE9C-47C4-BC8A-CCF8BB9B5BD4 Q37886401-B477C6FD-7659-4705-BD05-22BC8B7492A1 Q38930778-CADC306A-6131-4300-A6FF-E2D88FB74A05 Q38956740-33DF5842-39BA-4DD5-91B0-C9B8AE41A4D1 Q39680232-B091E4E9-7F58-40B9-9162-361AEDC7704B Q40963795-CAD09600-C623-4A68-8BE4-250D1DD03DBA Q44239401-0D293867-05AA-4209-89C8-C44D0BA300E6 Q46145950-DAC690BE-A7A0-4F8D-860A-24BA1E267763 Q46440419-F06B1ECA-15EE-463A-89BC-85DA0C197C18 Q46504216-CEC52406-9C90-4EE2-923A-3D5FC23CCD0F Q46864205-24A3724A-FF18-4DD5-8DFD-466E2D6B33B6 Q47608070-04D46D35-5F80-43A4-9612-115C8CCDB9D4 Q51063954-C7C80FC3-2E41-4AD4-B68C-7A27BCE37681 Q53526456-E7195D75-BEAE-4034-A521-3DE4E5035A80 Q53702255-5CD44C1C-7E79-4344-B3A0-742B915F211E Q58919601-0C145B60-6C32-47D4-9998-8681CB5AF4ED

P2860

Bone loss. Factors that regulate osteoclast differentiation: an update.

http://www.wikidata.org/entity/Q24805142

description

2000 nî lūn-bûn

@nan

2000 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած

@hyw

2000 թվականի սեպտեմբերին հրատարակված գիտական հոդված

@hy

2000年の論文

@ja

2000年論文

@yue

2000年論文

@zh-hant

2000年論文

@zh-hk

2000年論文

@zh-mo

2000年論文

@zh-tw

2000年论文

@wuu

name

Bone loss. Factors that regulate osteoclast differentiation: an update

@nl

Bone loss. Factors that regulate osteoclast differentiation: an update.

@ast

Bone loss. Factors that regulate osteoclast differentiation: an update.

@en

type

label

Bone loss. Factors that regulate osteoclast differentiation: an update

@nl

Bone loss. Factors that regulate osteoclast differentiation: an update.

@ast

Bone loss. Factors that regulate osteoclast differentiation: an update.

@en

prefLabel

Bone loss. Factors that regulate osteoclast differentiation: an update

@nl

Bone loss. Factors that regulate osteoclast differentiation: an update.

@ast

Bone loss. Factors that regulate osteoclast differentiation: an update.

@en

P1433

Q24805142-2081EF23-4C82-4213-A24D-067A17E27477

Q24805142-C7CE4B26-F2DF-4812-92FF-1202FE058953

P1476

Q24805142-E93AD2EC-0F89-4182-AF48-05F7B4D1F47D

P2093

Q24805142-99FF05F9-B516-4821-917C-BD9058DF5525

Q24805142-B4282CD8-DE8D-43FF-A5FE-10583162D0F7

P2860

Q24805142-0009AB52-763A-4D0B-A353-6E178E6CD785

Q24805142-03AC5C5E-9D48-4A99-ADB4-5E3E0DF4DBD7

Q24805142-1EED6D61-8709-4029-8190-04826E1B9838

Q24805142-296F275B-4BA0-4629-B2A3-945BEDB87BF1

Q24805142-2F4BE6FC-E5E6-4741-BCC5-958F897136EE

Q24805142-33E21351-7455-4FF9-91E7-E66C85769FBA

Q24805142-3BC35328-F6B6-4DDA-84B1-D4A24358A282

Q24805142-3E54E315-1CE9-4192-ACB0-A5942B1C0747

Q24805142-3F05C8FD-D7EA-4B09-BA8F-2C29708B6A5B

Q24805142-3FA1E2E3-ACC0-4149-9754-AFB49C13B032

P2888

Q24805142-1544C145-CA83-4990-A4B4-AD2319553B96

P304

Q24805142-A9EA2136-46F9-4C8D-A408-8E8595F2D43C

P31

Q24805142-03B3E747-C719-4F1E-83D6-E023C38734D8

Q24805142-80CE8ADE-5156-487B-8E4E-B37E3C85859B

P3181

Q24805142-2EA92093-5122-4F3C-B78D-E5F67DF1F075

P356

Q24805142-93B35913-C8BF-44D1-B282-408761E6CF83

P407

Q24805142-8159C6E8-E3ED-4A3D-BABC-E20EABB9560C

P433

Q24805142-C7919DC4-37B6-4C26-A8F7-D2841652AF10

P478

Q24805142-8650ECBD-871A-4ABB-8BE5-438E002101D5

P577

Q24805142-B213A867-DA7A-4B03-BAC3-0FE2803187D9

P5875

Q24805142-F09A8A64-FB91-4439-ABEF-BD0E63D8F4B9

P6179

Q24805142-F4EFFDF8-C14A-4A97-AEA4-D5F2EB731122

P698

Q24805142-0CECB72F-2346-496E-B899-98B4F7537C0B

P921

Q24805142-357082DB-B1A8-40B7-89F0-A5C37670B8BA

Q24805142-E3C55F52-AEE3-4C15-8712-F497A4ABACCE

P932

Q24805142-33B29586-6E12-4046-8223-E7DCE7A37A50

P3181

P356

P1433

Arthritis Research and Therapy

Arthritis Research

P1476

Bone loss. Factors that regulate osteoclast differentiation: an update.

@en

P2093

Orcel P

http://www.w3.org/2001/XMLSchema#string

Roux S

http://www.w3.org/2001/XMLSchema#string

P2860

Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation

Osteoprotegerin: a novel secreted protein involved in the regulation of bone density

TRANCE is a novel ligand of the tumor necrosis factor receptor family that activates c-Jun N-terminal kinase in T cells

Isolation of a novel cytokine from human fibroblasts that specifically inhibits osteoclastogenesis

A homologue of the TNF receptor and its ligand enhance T-cell growth and dendritic-cell function

RANK is essential for osteoclast and lymph node development

osteoprotegerin-deficient mice develop early onset osteoporosis and arterial calcification

Tumor necrosis factor receptor family member RANK mediates osteoclast differentiation and activation induced by osteoprotegerin ligand

Osteoclast differentiation factor is a ligand for osteoprotegerin/osteoclastogenesis-inhibitory factor and is identical to TRANCE/RANKL

Modulation of osteoclast differentiation and function by the new members of the tumor necrosis factor receptor and ligand families

P2888

P304

451-456

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

3438102

http://www.w3.org/2001/XMLSchema#string

P356

10.1186/AR127

http://www.w3.org/2001/XMLSchema#string

P407

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

2

http://www.w3.org/2001/XMLSchema#string

P577

2000-09-06T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

235433937

http://www.w3.org/2001/XMLSchema#string

P6179

1022482528

http://www.w3.org/2001/XMLSchema#string

P698

11094458

http://www.w3.org/2001/XMLSchema#string

P921

P932

128874

http://www.w3.org/2001/XMLSchema#string